Patents Prosecuted
Application number | Title of the patent | IPC | Filing Date | Decision Date |
---|---|---|---|---|
17627066 | METHOD FOR DETERMINING AT LEAST ONE PARAMETER OF A SAMPLE COMPOSITION COMPRISING NUCLEIC ACID, SUCH AS RNA, AND OPTIONALLY PARTICLES | G01N | Jul 16, 2020 | |
16920286 | Individualized vaccines for cancer | C12Q, A61K, G16B | Jul 1, 2020 | Feb 14, 2022 |
17621396 | IL2 Agonists | A61P, C07K | Jun 22, 2020 | |
16898176 | STABILIZATION OF POLY(A) SEQUENCE ENCODING DNA SEQUENCES | C12N, A61K, C12P | Jun 9, 2020 | |
17593391 | PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPY | A61K | Mar 31, 2020 | |
17599468 | COMPOSITIONS AND METHODS FOR PREPARING T CELL COMPOSITIONS AND USES THEREOF | C12N, A61K | Mar 29, 2020 | |
17599179 | CANCER BIOMARKERS FOR DURABLE CLINICAL BENEFIT | A61K, A61P, C12Q | Mar 26, 2020 | |
17432017 | PROCESS FOR THE PREPARATION OF A SUBSTITUTED IMIDAZOQUINOLINE | C07D | Mar 5, 2020 | |
16749012 | Particles comprising a shell with RNA | C12N, A61K | Jan 21, 2020 | May 29, 2023 |
16735555 | T cell manufacturing compositions and methods | C12N, A61K, A61P | Jan 5, 2020 | Nov 1, 2021 |
16692544 | HLA-based methods and compositions and uses thereof | G16B, G01N, C40B, A61K | Nov 21, 2019 | May 15, 2023 |
16595440 | PEPTIDE MIMOTOPES OF CLAUDIN 18.2 AND USES THEREOF | G01N, A61K, C07K | Oct 6, 2019 | Sep 4, 2023 |
16582534 | Agonistic tumor necrosis factor (TNF) receptor binding agents | C07K | Sep 24, 2019 | Feb 22, 2021 |
16578601 | RNA formulation for immunotherapy | A61K | Sep 22, 2019 | Jan 23, 2023 |
16552248 | Therapeutic RNA | A61K, A61P | Aug 26, 2019 | Jun 29, 2023 |
17268915 | T CELL RECEPTOR CONSTRUCTS AND USES THEREOF | C07K, A61K | Aug 15, 2019 | |
17262180 | Individualized Vaccines for Cancer | C12Q, A61P, A61K | Jul 22, 2019 | |
17262097 | IL2 Agonists | A61K, C07K, A61P | Jul 18, 2019 | |
17251285 | COMBINATION THERAPY WITH NEOANTIGEN VACCINE | A61P, A61K | Jun 10, 2019 | |
16972794 | Compositions and methods for diagnosis and treatment of cancer | A61K, C07K, G01N | Jun 5, 2019 | Jun 12, 2023 |